2m 2m 2m 2m 2m 2m 2m
DIAMEDICA THERAP (DMAC)
NASDAQ
$8.24-$0.12 (-1.38%)
Price as of Oct 02, 2026 5:01 PM EDT- $450.3MMarket Cap
- 19.29%1-Year Change
- BiotechnologyIndustry
DIAMEDICA THERAP (DMAC)
$8.24-$0.12 (-1.38%)
DMAC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.35 | ||
Change | +$0.08 (+0.97%) | ||
Open | $8.33 | ||
High | $8.54 | ||
Low | $8.10 | ||
Previous Close | $8.27 | ||
Volume | 234,219 | ||
30-Day Average Volume | 201,056 | ||
1-Week Change | 6.64% | ||
1-Month Change | 29.46% | ||
1-Year Change | 19.29% | ||
3-Year Change | 223.64% | ||
5-Year Change | 100.24% | ||
Fundamentals | |||
Shares Outstanding | 53.9M | ||
Total Assets | $45.0M | ||
Market Cap | $450.3M | ||
Enterprise Value | $445.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$10.0M | ||
Free Cash Flow | -$9.1M | ||
EBIT | -$10.0M | ||
EBITDA | -$10.0M | ||
Net Working Capital | $46.6M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -44 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 10 | ||
P/E | -44 | ||
PEG | 3 | ||
Price/Free Cash Flow | -50 | ||
Price/Operating Cash Flow | -50 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue